Stocklytics Platform
Asset logo for symbol MCK
McKesson
MCK
72
$608.41arrow_drop_up0.09%$0.60
High Growth
S&P500

Performance History

Chart placeholder
Key Stats
Open$608.48
Prev. Close$607.81
EPS22.37
Dividend$2.48
Next Earnings DateSep 30, 2024
Dividend Yield %0.41%
Market Cap$78.39B
PE Ratio27.21
LOWHIGH
Day Range605.90
611.02
52 Week Range395.29
611.02
Ratios
P/B Ratio5.04
Revenue-
Operating M. %1.51%
Earnings$3.00B
Earnings Growth %-19.34%
EBITDA Margin %1.65%
ROE %0.00%
EPS22.37

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

Correlated Companies

Price$903.75
Perf. (24h)
arrow_drop_up1.53%$13.64
Market Cap$840.04B
Price$485.74
Perf. (24h)
arrow_drop_down0.86%-$4.23
Market Cap$451.00B
Price$147.31
Perf. (24h)
arrow_drop_down1.21%-$1.81
Market Cap$357.99B
Price$133.14
Perf. (24h)
arrow_drop_up0.14%$0.18
Market Cap$331.08B

About McKesson (MCK)

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners and patients to address medication challenges for patients by working across healthcare; connects patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver innovative solutions to help people get the medicine needed to live healthier lives; and provides prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. The International segment offers distribution and services to wholesale, institutional, and retail customers in Europe and Canada. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.

Sector
Healthcare
Industry
Medical Distribution
CEO
Mr. Brian S. Tyler Ph.D.
Headquarters
Irving
Employees
45000
Exchange
NYSE
add McKesson to watchlist

Keep an eye on McKesson

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help
What is McKesson's (MCK) price per share?

The current price per share for McKesson (MCK) is $608.66. The stock has seen a price change of $0.85 recently, indicating a 0.14% change. This reflects the stock's recent market performance and investor sentiment.

help
What is the 52-week high and low for McKesson (MCK)?

For McKesson (MCK), the 52-week high is $611.02, which is 0.39% from the current price. The 52-week low is $395.3, the current price is 53.97% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help
Is McKesson (MCK) a growth stock?

McKesson (MCK) has shown an average price growth of 0.41% over the past three years. It has received a score of 90 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying McKesson as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help
What is McKesson (MCK) stock price performance year to date (YTD)?

As of the latest data, McKesson (MCK) has a year-to-date price change of 28.57%. Over the past month, the stock has experienced a price change of 8.55%. Over the last three months, the change has been 14.29%. Over the past six months, the figure is 33.55%. Looking at a longer horizon, the five-year price change stands at 364.17%.

help
Is McKesson (MCK) a profitable company?

McKesson (MCK) has a net income of $3B, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 3.95% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 1.51% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , with a revenue growth rate of 11.65%, providing insight into the company's sales performance and growth. The gross profit is $12.2B. Operating income is noted at $3.93B. Furthermore, the EBITDA is $4.96B.

help
What is the market capitalization of McKesson (MCK)?

McKesson (MCK) has a market capitalization of $78.39B. The average daily trading volume is 584.11K, indicating the stock's liquidity and investor engagement.

News

email

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level